Schreiber R - Search Results

1

Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.

Shao L, Ma J, Wang F, Malcolm SC, Hewitt MC, Campbell UC, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA. Shao L, et al. Among authors: schreiber r. Bioorg Med Chem Lett. 2011 Jan 1;21(1):520-3. doi: 10.1016/j.bmcl.2010.10.086. Epub 2010 Oct 28. Bioorg Med Chem Lett. 2011. PMID: 21095126

2

Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.

Shao L, Wang F, Malcolm SC, Ma J, Hewitt MC, Campbell UC, Bush LR, Spicer NA, Engel SR, Saraswat LD, Hardy LW, Koch P, Schreiber R, Spear KL, Varney MA. Shao L, et al. Among authors: schreiber r. Bioorg Med Chem. 2011 Jan 1;19(1):663-76. doi: 10.1016/j.bmc.2010.10.034. Epub 2010 Oct 21. Bioorg Med Chem. 2011. PMID: 21093273

3

Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.

Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA. Shao L, et al. Among authors: schreiber r. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1438-41. doi: 10.1016/j.bmcl.2011.01.016. Epub 2011 Jan 12. Bioorg Med Chem Lett. 2011. PMID: 21310609

4

Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.

Shao L, Hewitt MC, Wang F, Malcolm SC, Ma J, Campbell JE, Campbell UC, Engel SR, Spicer NA, Hardy LW, Schreiber R, Spear KL, Varney MA. Shao L, et al. Among authors: schreiber r. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1434-7. doi: 10.1016/j.bmcl.2011.01.019. Epub 2011 Jan 12. Bioorg Med Chem Lett. 2011. PMID: 21310612

5

Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.

Shao L, Hewitt MC, Malcolm SC, Wang F, Ma J, Campbell UC, Spicer NA, Engel SR, Hardy LW, Jiang ZD, Schreiber R, Spear KL, Varney MA. Shao L, et al. Among authors: schreiber r. J Med Chem. 2011 Aug 11;54(15):5283-95. doi: 10.1021/jm101312a. Epub 2011 Jul 8. J Med Chem. 2011. PMID: 21739935

6

In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo.

Schreiber R, Campbell U, Quinton MS, Hardy LW, Fang QK, Lew R. Schreiber R, et al. Biomed Pharmacother. 2022 Sep;153:113359. doi: 10.1016/j.biopha.2022.113359. Epub 2022 Jul 1. Biomed Pharmacother. 2022. PMID: 35785702 Free article.

7

The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.

Breuer ME, Chan JS, Oosting RS, Groenink L, Korte SM, Campbell U, Schreiber R, Hanania T, Snoeren EM, Waldinger M, Olivier B. Breuer ME, et al. Among authors: schreiber r. Eur Neuropsychopharmacol. 2008 Dec;18(12):908-16. doi: 10.1016/j.euroneuro.2008.07.011. Epub 2008 Sep 11. Eur Neuropsychopharmacol. 2008. PMID: 18789657

8

Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.

van Goethem NP, Schreiber R, Newman-Tancredi A, Varney M, Prickaerts J. van Goethem NP, et al. Among authors: schreiber r. Br J Pharmacol. 2015 May;172(10):2532-43. doi: 10.1111/bph.13071. Epub 2015 Feb 27. Br J Pharmacol. 2015. PMID: 25572672 Free PMC article.

9

Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.

Vinkers CH, Olivier B, Hanania T, Min W, Schreiber R, Hopkins SC, Campbell U, Paterson N. Vinkers CH, et al. Among authors: schreiber r. Eur J Pharmacol. 2011 Oct 1;668(1-2):190-3. doi: 10.1016/j.ejphar.2011.06.054. Epub 2011 Jul 8. Eur J Pharmacol. 2011. PMID: 21762686

10

Biased 5-HT_1A receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment.

van Hagen BTJ, van Goethem NP, Nelissen E, Paes D, Koymans K, van Hoof S, Schreiber R, Varney M, Newman-Tancredi A, Prickaerts J. van Hagen BTJ, et al. Among authors: schreiber r. Mol Cell Neurosci. 2022 May;120:103719. doi: 10.1016/j.mcn.2022.103719. Epub 2022 Mar 10. Mol Cell Neurosci. 2022. PMID: 35283305 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,157 results

Search Page

Filters